Intellectus Partners’s Exact Sciences EXAS Stock Holding History

Intellectus Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,800	Closed	-$238K	–	249
2020 Q4	$238K	Buy	+1,800	New	+$218K	0.07%	213
2020 Q3	–	Sell	-2,800	Closed	-$243K	–	215
2020 Q2	$243K	Buy	+2,800	New	+$224K	0.09%	189
2019 Q2	–	Sell	-500	Closed	-$43K	–	255
2019 Q1	$43K	Buy	+500	New	+$42.6K	0.02%	264
2018 Q4	–	Sell	-10,000	Closed	-$789K	–	339
2018 Q3	$789K	Hold	10,000	–	–	0.28%	107
2018 Q2	$598K	Hold	10,000	–	–	0.22%	120
2018 Q1	$403K	Hold	10,000	–	–	0.14%	161
2017 Q4	$525K	Hold	10,000	–	–	0.2%	130
2017 Q3	$471K	Hold	10,000	–	–	0.2%	125
2017 Q2	$354K	Hold	10,000	–	–	0.16%	149
2017 Q1	$236K	Hold	10,000	–	–	0.12%	165
2016 Q4	$134K	Buy	+10,000	New	+$161K	0.07%	202

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Intellectus Partners's EXAS Position: Q1 2021 in Review

Intellectus Partners sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 1,800 shares — an estimated $238K sold.

Intellectus Partners first reported a position in EXAS in Q4 2016 and held it in 11 quarters. The position peaked at $789K in Q3 2018. 646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

Intellectus Partners reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
Intellectus Partners sold 1,800 Exact Sciences shares in Q1 2021, an estimated $238K.
Intellectus Partners first reported a position in Exact Sciences in Q4 2016 and held it in 11 quarters.
Intellectus Partners's Exact Sciences position peaked at $789K in Q3 2018.
646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Intellectus Partners's 13F filing for Q1 2021, filed 17 May 2021.